Skip to main content

Advertisement

Log in

Expression of p27 and p16 and their clinical significance in gastric cancer

  • Research Article
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Background

Deregulated expression of cell cycle regulators p27 and p16 is associated with cancer progression. p27kip1 and p16INKa are a cyclin dependent kinase inhibitor whose major target is the cyclinE/CDK2 and cyclinD/CDK4/6 complex, respectively, that governs cell cycle transition from late G1 to S phase.

Methods

We recruited biopsies of a total of 84 subjects including 72 primary tumor biopsies from histopathologically proven gastric carcinoma, 8 adjacent controls and 12 independent controls. We used gastric cancer cell line, AGS, for validation of our data. Expression profiling at transcript level was done by semi-quantitative RT-PCR and at proteome level by immunohistochemistry and immunofluorescence. Receiver operator characteristics analysis was done for determining the diagnostic utility of p27 and p16 with respect to the sensitivity and specificity.

Results

We demonstrate that p27 and p16 are frequently over expressed in early stages of gastric carcinoma. Our semi-quantitative data show a significant upregulation of p27 (Mean ± SEM, 0.4771 ± 0.0895; p = 0.0001) and p16 (Mean ± SEM, 0.4676 ± 0.04305; p = 0.0001) at mRNA level. Concordant to semi-quantitative data, immunohistochemistry data also showed a significant upregulation of p27 (Mean ± SEM, 196.4 ± 10.84; p < 0.0001) and p16 (Mean ± SEM, 100.4 ± 23.71; p < 0.0001) at protein level.

Conclusions

The present study showed that the significant upregulation of p27 and p16 were associated with early events in gastric carcinogenesis. Our data suggests that clinical correlation of these differentially expressed genes may be useful as diagnostic biomarkers for early detection of gastric carcinoma and promising therapeutics target for GC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.

    Article  Google Scholar 

  2. Dikshit R, Gupta PC, Ramasundarahettige C, Gajalakshmi V, Aleksandrowicz L, Badwe R, et al. Cancer mortality in India: a nationally representative survey. Lancet. 2012;379:1807–16.

    Article  Google Scholar 

  3. Chu IM, Hengst L, Slingerland JM. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer. 2008;8:253–67.

    Article  CAS  Google Scholar 

  4. Yasui W, Oue N, Kuniyasu H, Ito R, Tahara E, Yokozaki H. Molecular diagnosis of gastric cancer: present and future. Gastric Cancer. 2001;4:113–21.

    Article  CAS  Google Scholar 

  5. Viglietto G, Motti ML, Fusco A. Understanding p27(kip1) deregulation in cancer: down-regulation or mislocalization. Cell Cycle. 2002;1:394–400.

    Article  CAS  Google Scholar 

  6. Lloyd RV, Erickson LA, Jin L, Kulig E, Qian X, Cheville JC, et al. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol. 1999;154:313–23.

    Article  CAS  Google Scholar 

  7. Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med. 1997;3:231–4.

    Article  CAS  Google Scholar 

  8. Tan P, Cady B, Wanner M, Worland P, Cukor B, Magi- Galluzzi C, et al. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a, b) invasive breast carcinomas. Cancer Res. 1997;57:1259–63.

    CAS  PubMed  Google Scholar 

  9. Masciullo V, Sgambato A, Pacilio C, Pucci B, Ferrandina G, Palazzo J, et al. Frequent loss of expression of the cyclindependent kinase inhibitor p27 in epithelial ovarian cancer. Cancer Res. 1999;59:3790–4.

    CAS  PubMed  Google Scholar 

  10. Gillett CE, Smith P, Peters G, Lu X, Barnes DM. Cyclin dependent kinase inhibitor p27Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma. J Pathol. 1999;187:200–6.

    Article  CAS  Google Scholar 

  11. Barbareschi M, van Tinteren H, Mauri FA, Veronese S, Peterse H, Maisonneuve P, et al. p27(kip1) expression in breast carcinomas: an immunohistochemical study on 512 patients with long-term follow-up. Int J Cancer. 2000;89:236–41.

    Article  CAS  Google Scholar 

  12. Sgambato A, Ratto C, Faraglia B, Merico M, Ardito R, Schinzari G, et al. Reduced expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in human colon cancer. Mol Carcinog. 1999;26:172–9.

    Article  CAS  Google Scholar 

  13. Zhang H, Sun XF. Loss of p27 expression predicts poor prognosis in patients with Dukes’ B stage or proximal colorectal cancer. Int J Oncol. 2001;19:49–52.

    CAS  PubMed  Google Scholar 

  14. Singh SP, Lipman J, Goldman H, Ellis FH Jr, Aizenman L, Cangi MG, et al. Loss or altered subcellular localization of p27 in Barrett’s associated adenocarcinoma. Cancer Res. 1998;58:1730–5.

    CAS  PubMed  Google Scholar 

  15. Babaei M, Pourfarzi F, Yazdanbod A, Chiniforush MM, Derakhshan MH, Mousavi SM, et al. Gastric cancer in Ardabil, Iran–a review and update on cancer registry data. Asian Pac J Cancer Prev. 2010;11:595–9.

    PubMed  Google Scholar 

  16. Hansson LE, Baron J, Nyrén O, Bergström R, Wolk A, Adami HO. Tobacco, alcohol and the risk of gastric cancer. A population-based case-control study in Sweden. Int J Cancer. 1994;57:26–31.

    Article  CAS  Google Scholar 

  17. Kulkarni S, Rader JS, Zhang F, Liapis H, Koki AT, Masferrer JL. Cyclooxygenase-2 over expressed in human cervical cancer. Clin Cancer Res. 2001;7:429–34.

    CAS  PubMed  Google Scholar 

  18. Prasad SB, Yadav SS, Das M, Modi A, Kumari S, Pandey LK, et al. PI3K/AKT pathway-mediated regulation of p27(Kip1) is associated with cell cycle arrest and apoptosis in cervical cancer. Cell Oncol. 2015;38:215–25.

    Article  CAS  Google Scholar 

  19. Lee YY, Derakhshan MH. Environmental and lifestyle risk factors of gastric cancer. Arch Iran Med. 2013;16:358–65.

    PubMed  Google Scholar 

  20. Chandanos E, Lagergren J. Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer. 2008;44:2397–403.

    Article  CAS  Google Scholar 

  21. Qin J, Liu M, Ding Q, Ji X, Hao Y, Wu X, et al. The direct effect of estrogen on cell viability and apoptosis in human gastric cancer cells. Mol Cell Biochem. 2014;395:99–107.

    Article  CAS  Google Scholar 

  22. Gamboa-Dominguez A, Seidl S, Reyes-Gutierrez E, Hermannstädter C, Quintanilla-Martinez L, Busch R, Höfler H, et al. Prognostic significance of p21WAF1/CIP1, p27Kip1, p53 and E-cadherin expression in gastric cancer. J Clin Pathol. 2007;60:756–61.

    Article  CAS  Google Scholar 

  23. Sugai T, Tsukahara M, Endoh M, Shioi Y, Takebe N, Mue Y, et al. Analysis of cell cycle-related proteins in gastric intramucosal differentiated-type cancers based on mucin phenotypes: a novel hypothesis of early gastric carcinogenesis based on mucin phenotype. BMC Gastroenterol. 2010;10:55.

    Article  Google Scholar 

  24. Kumari S, Puneet PSB, Yadav SS, Kumar M, Khanna A, et al. Cyclin D1 and cyclin E2 are differentially expressed in gastric cancer. Med Oncol. 2016;33:40.

    Article  Google Scholar 

  25. Ito Y, Matsuura N, Sakon M, Miyoshi E, Noda K, Takeda T, et al. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence. Hepatology. 1999;30:90–9.

    Article  CAS  Google Scholar 

  26. Wang Y, Wang Y, Cheng C, Ji Y, Zhao Y, Zou L, et al. Expression of Jun activation domain-binding protein 1 and Ser10 phosphorylated p27 protein in human epithelial ovarian carcinoma. J Cancer Res Clin Oncol. 2009;135:951–9.

    Article  CAS  Google Scholar 

  27. Hwang CS, Ahn S, Lee BE, Lee SJ, Kim A, Choi CI, et al. Risk of lymph node metastasis in mixed-type early gastric cancer determined by the extent of the poorly differentiated component. World J Gastroenterol. 2016;22:4020–6.

    Article  Google Scholar 

  28. Baekelandt M, Holm R, Tropé CG, Nesland JM, Kristensen GB. Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: an immunohistochemical study. Clin Cancer Res. 1999;5:2848–53.

    CAS  PubMed  Google Scholar 

  29. Kang HY, Kim N, Park YS, Hwang JH, Kim JW, Jeong SH, et al. Progression of atrophic gastritisand intestinal metaplasia drives Helicobacter pylori out of thegastric mucosa. Dig Dis Sci. 2006;51:2310–5.

    Article  Google Scholar 

  30. Melck A, Masoudi H, Griffith OL, Rajput A, Wilkins G, Bugis S, et al. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer. Ann Surg Oncol. 2007;14:3403–11.

    Article  Google Scholar 

Download references

Acknowledgements

Authors acknowledge financial assistance from Department of Biotechnology (DBT), Ministry of Science and Technology, India to Dr. Puneet (BT/PR/11113/10/678/2008); Soni Kumari is thankful to DBT and Banaras Hindu University for Research Fellowships. Authors are thankful to Interdisciplinary School of Life Sciences, Banaras Hindu University and UGC-UPE programme of Banaras Hindu University for equipment facilities.

Funding

This study was funded by Department of Biotechnology, Government of India, vide Grant number BT/PR11113/BRB/10/678/ 2008 to Dr. Puneet and financial assistance from Banaras Hindu University to Soni Kumari.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Kumar.

Ethics declarations

Conflict of interest

Authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki Declaration ethical standards and approved by the Institutional Ethical Committee of Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.

Informed consent

Written informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kumari, S., Kumar, P., Kumar, M. et al. Expression of p27 and p16 and their clinical significance in gastric cancer. Clin Transl Oncol 23, 856–865 (2021). https://doi.org/10.1007/s12094-020-02479-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-020-02479-4

Keywords

Navigation